Skip to main content
Publications
Aiyegbusi OL, Cruz Rivera S, Roydhouse J, Kamudoni P, Alder Y, Anderson N, Baldwin RM, Bhatnagar V, Black J, Bottomley A, Brundage M, Cella D, Collis P, Davies EH, Denniston AK, Efficace F, Gardner A, Gnanasakthy A , Golub RM, Hughes SE, Jeyes F, Kern S, King-Kallimanis BL, Martin A, McMullan C, Mercieca-Bebber R, Monteiro J, Peipert JD, Quijano-Campos JC, Quinten C, Rantell KR, Regnault A, Sasseville M, Schougaard LMV, Sherafat-Kazemzadeh R, Snyder C, Stover AM, Verdi R, Wilson R, Calvert MJ. Recommendations to address respondent burden associated with patient-reported outcome assessment . Nat Med. 2024 Mar;30(3):650-9. doi: 10.1038/s41591-024-02827-9
Ribera A, Marsal JR , Faixedas MT, Rosas A, Tizon-Marcos H, Rojas S, Labata C, Cardenas M, Homs S, Tomas-Querol C, Garcia-Picart J, Roura G, Masotti M, Mauri J, Pijoan JI, Barrabes JA, Ferreira-Gonzalez I, Codi IAM Investigators Investigators. Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes . Rev Esp Cardiol. 2022 Aug;75(8):659-68. doi: 10.1016/j.rec.2021.10.011.
Metcalfe KA, Price MA, Mansfield C , Hallett DC, Lindeman GJ, Fairchild A, Posner J, Friedman S, Snyder C, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Lynch HT, Evans DG, Narod SA, Liede A. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis . Br J Cancer. 2020 Jul 21;123:268-74. doi: 10.1038/s41416-020-0861-3
Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martinez-Cardus A, Marin-Aguilera M, Horndler C, Martinez-Balibrea E, Rubini M, Jares P, Reig O, Victoria I, Gaba L, Martin-Richard M, Alonso V, Escudero P, Fernandez-Martos C, Feliu J, Mendez JC, Mendez M, Gallego J, Salud A, Rojo F, Castells A, Prat A, Rosell R, Garcia-Albeniz X , Camps J, Maurel J. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer . Br J Cancer. 2017 Dec 5;117(12):1777-86. doi: 10.1038/bjc.2017.279.
Garcia-Albeniz X , Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, Thornquist M, Le Marchand L, Potter J, Slattery ML, Zanke B, Baron JA, Caan BJ, Chanock SJ, Berndt SI, Stelling D, Fuchs CS, Hoffmeister M, Butterbach K, Du M, James Gauderman W, Gunter MJ, Lemire M, Ogino S, Lin J, Hayes RB, Haile RW, Schoen RE, Warnick GS, Jenkins MA, Thibodeau SN, Schumacher FR, Lindor NM, Kolonel LN, Hopper JL, Gong J, Seminara D, Pflugeisen BM, Ulrich CM, Qu C, Duggan D, Cotterchio M, Campbell PT, Carlson CS, Newcomb PA, Giovannucci E, Hsu L, Chan AT, Peters U, Chang-Claude J. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk . Br J Cancer. 2016 Jan 19;114(2):221-9. doi: 10.1038/bjc.2015.443
Ferreira-Gonzalez I, Permanyer Miralda G, Heras M, Ribera A, Marsal JR , Cascant P, Aros F, Bueno H, Sanchez PL, Cunat J, Civeira E, Marrugat J, Investigadores del Estudio MASCARA. Prognosis and management of patients with acute coronary syndrome and polyvascular disease . Rev Esp Cardiol. 2009 Sep;62(9):1012-21. doi: 10.1016/s1885-5857(09)73267-0
Ribera A, Ferreira-Gonzalez I, Cascant P, Marsal JR , Romero B, Pedrol D, Martinez-Useros C, Pons JM, Fernandez T, Permanyer-Miralda G, ARCA Study Investigators. Survival, clinical status and quality of life five years after coronary surgery. The ARCA study . Rev Esp Cardiol. 2009 Jun;62(6):642-51. doi: 10.1016/s1885-5857(09)72228-5